Cidara Therapeutics (CDTX) shares were 72% higher pre-bell Monday after the company reported a phase 2b trial of CD388 for the prevention of seasonal influenza in healthy unvaccinated adults aged 18 to 64 met its primary endpoint and all secondary efficacy endpoints for all dose groups.
OceanPal (OP) stock was up 61%, rebounding from Friday's drop.
Houston American Energy (HUSA) shares were 35% higher, reversing losses in the previous session.
Robin Energy (RBNE) stock was up 30%, erasing Friday's losses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.